Sign in
8-K

Current Report

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001048477-24-000132

Exit or restructuring costs

  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading bmrn-20240823.htm…